KMT2C mutation associated with tumor mutational burden in small cell lung cancer.

Weiguang Gu,Hongbiao Wang,Kunsong Li,Ge Wei,Junkai Zhang,Shiyue Zhang,Lin Zhang,Xiaoliang Shi,Angen Liu

KMT2C mutation associated with tumor mutational burden in small cell lung cancer.

2019

Weiguang Gu
Hongbiao Wang
Kunsong Li
Ge Wei
Junkai Zhang
Shiyue Zhang
Lin Zhang
Xiaoliang Shi
Angen Liu

e20098Background: Immune checkpoint inhibitors are used to treat small cell lung cancer (SCLC). Tumor mutational burden (TMB) emerges as a promising predictor of immunotherapy efficacy, but the rel...

Keywords:

Cancer research
Cell
Lung cancer
Immunotherapy
Immune checkpoint
Pathology
Medicine
Mutation
non small cell
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations